High flow nasal oxygen therapy to avoid invasive mechanical ventilation in SARS-CoV-2 pneumonia: a retrospective study
Nicolas Bonnet(Sorbonne Université), Yves Cohen, Mohamed Ghalayini(Assistance Publique – Hôpitaux de Paris), Guillaume Van Der Meersch(Hôpital Avicenne), Vincent Lévy(Hôpital Avicenne), Yacine Tandjaoui-Lambiotte(Université Sorbonne Paris Nord), Anaïs Winchenne(Hôpital Necker-Enfants Malades), Marie Soulié(Assistance Publique – Hôpitaux de Paris), Marouane Boubaya(Université Paris-Seine), Stèphane Gaudry(Inserm), Philippe Karoubi, Olivier Martin(Hospices Civils de Lyon), Jean Ralph Zahar(Centre Hospitalier Universitaire d'Angers), Nathan Ebstein, Johanna Oziel(Assistance Publique – Hôpitaux de Paris), Passem Ahmed
Cited by 102
Related Papers
Mapping and predicting mortality from systemic sclerosis
|Annals of the Rheumatic Diseases|2017|699
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
|Science Immunology|2021|638